Evidence map›Paper›PMID 23749115›Full record

ArticleInternational journal of molecular sciences2013

Contribution of the Tyr-1 in Plantaricin149a to disrupt phospholipid model membranes.

José L S Lopes, Maria J Gómara, Isabel Haro, Georgina Tonarelli, Leila M Beltramini

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

José L S LopesInstitute of Physics of Sao Carlos, University of Sao Paulo, Av. Trabalhador Saocarlense 400, Sao Carlos, SP 13560-970, Brazil. leila@ifsc.usp.br.
Maria J Gómara
Isabel Haro
Georgina Tonarelli
Leila M Beltramini

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plantaricin149a (Pln149a) is a cationic antimicrobial peptide, which was suggested to cause membrane destabilization via the carpet mechanism. The mode of action proposed to this antimicrobial peptide describes the induction of an amphipathic α-helix from Ala7 to Lys20, while the N-terminus residues remain in a coil conformation after binding. To better investigate this assumption, the purpose of this study was to determine the contributions of the Tyr1 in Pln149a in the binding to model membranes to promote its destabilization. The Tyr to Ser substitution increased the dissociation constant (KD) of the antimicrobial peptide from the liposomes (approximately three-fold higher), and decreased the enthalpy of binding to anionic vesicles from -17.2 kcal/mol to -10.2 kcal/mol. The peptide adsorption/incorporation into the negatively charged lipid vesicles was less effective with the Tyr1 substitution and peptide Pln149a perturbed the liposome integrity more than the analog, Pln149S. Taken together, the peptide-lipid interactions that govern the Pln149a antimicrobial activity are found not only in the amphipathic helix, but also in the N-terminus residues, which take part in enthalpic contributions due to the allocation at a lipid-aqueous interface.

Indexed as

Amino Acid SequenceAnti-Infective AgentsBacteriocinsCalorimetryCircular DichroismHemolysisHumansLiposomesMicrobial Sensitivity TestsMolecular Sequence DataNaphthalenesPeptidesPhosphatidylglycerolsPhospholipidsPyridinium CompoundsSpectrometry, Fluorescence1,2-dipalmitoylphosphatidylglycerol8-amino-1,3,6-naphthalenetrisulfonic acidAnti-Infective AgentsBacteriocinsLiposomesNaphthalenesN,N'-4-xylylenebis(pyridinium)PeptidesPhosphatidylglycerolsPhospholipidsplantaricin 149Pyridinium CompoundsTryptophanTyrosine

Identifiers

PMID23749115
PMCPMC3709787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.